Physician profile
Anayo Umerah
NPI 1003986761
$23,227.95
in general payments reported to CMS, 2019-2025
16 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $89.68 · 2021: $490 · 2022: $71.05 · 2023: $61.80 · 2024: $184 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $357.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $22,219.92 | 2019 | |
| Merz North America, INC. | $575.45 | 2020-2023 | Xeomin |
| Galderma Laboratories, L.P. | $99.50 | 2020-2023 | |
| Astrazeneca Pharmaceuticals Lp | $57.76 | 2024-2025 | Farxiga |
| Lilly USA, LLC | $37.78 | 2024-2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $34.90 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Novo Nordisk INC | $34.02 | 2024-2025 | Ozempic |
| Abbvie INC. | $29.84 | 2025 | |
| Daiichi Sankyo INC. | $23.67 | 2020 | |
| Abbott Laboratories | $20.39 | 2024 | Freestyle Libre |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.47 | 2024 | Trulance, Xifaxan |
| Otsuka America Pharmaceutical, INC. | $18.42 | 2024 | Rexulti |
| Amgen INC. | $15.58 | 2024 | Repatha, Otezla |
| Dexcom, INC. | $14.48 | 2024 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $13.89 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $13.88 | 2024 | Minimed 780g |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anayo Umerah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.